Atopic dermatitis exacerbation after Covid-19 vaccination in Dupilumab-treated patients

J Eur Acad Dermatol Venereol. 2022 Jun;36(6):e409-e411. doi: 10.1111/jdv.17964. Epub 2022 Feb 4.

Authors

L Potestio¹, M Napolitano², L Bennardo³, G Fabbrocini¹, C Patruno³

Affiliations

¹ Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
² Department of Medicine and Health Sciences Vincenzo Tiberio, University of Molise, Campobasso, Italy.
³ Department of Health Sciences, University Magna Graecia of Catanzaro, Catanzaro, Italy.

PMID: 35067996
DOI: 10.1111/jdv.17964

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized
COVID-19 Vaccines / adverse effects
COVID-19* / prevention & control
Dermatitis, Atopic* / drug therapy
Humans
Treatment Outcome
Vaccination / adverse effects

Substances

Antibodies, Monoclonal, Humanized
COVID-19 Vaccines
dupilumab